Johnson & Johnson: to fight against HIV and tuberculosis
(CercleFinance.com) - Johnson & Johnson is committed to providing up to 500 million dollars in global research and development and delivery programs over the next four years to help eradicate HIV and tuberculosis by 2030.
"By advancing our technologies, uniting our best scientists and leveraging decades of experience in HIV and TB, we're optimistic that we can make a significant contribution to the global effort," says the health group.
J&J will dedicate a team of world-class researchers, using its scientific resources to accelerate the discovery, development and delivery of next-generation medicines and vaccines to complement investments being made by governments.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
"By advancing our technologies, uniting our best scientists and leveraging decades of experience in HIV and TB, we're optimistic that we can make a significant contribution to the global effort," says the health group.
J&J will dedicate a team of world-class researchers, using its scientific resources to accelerate the discovery, development and delivery of next-generation medicines and vaccines to complement investments being made by governments.
Copyright (c) 2019 CercleFinance.com. All rights reserved.